FIELD: medicine.
SUBSTANCE: invention relates to doses and schemes of administration of an antibody to C5. Pharmaceutical compositions intended for the use for treatment or prevention of C5-related disease and methods for treatment or prevention of C5-related disease are described. Doses and schemes of administration of an antibody to C5 or pharmaceutical compositions containing an antibody to C5 are also described.
EFFECT: obtainment of pharmaceutical compositions for treatment or prevention of C5-related disease.
15 cl, 11 ex, 4 tbl, 11 dwg
| Title |
Year |
Author |
Number |
| C5 ANTIBODIES AND THEIR APPLICATION METHODS |
2015 |
- Ruike Esinao
- Sampej Dzendziro
|
RU2746356C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF IL-8-RELATED DISEASES |
2017 |
- Kakiuti Ayako
- Kato Atsukhiko
- Khayasi Syudzi
- Yanagisava Idzumi
- Konno Re
- Netsu Satikho
- Sankai Tadasi
|
RU2766112C2 |
| ANTI-C5 ANTIBODIES AND METHODS FOR THEIR USE |
2017 |
- Rujke Esinao
- Sampej Dzendziro
|
RU2789788C2 |
| PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY |
2008 |
- Shreter Salli
- Gejms Kejt Dora
|
RU2523894C2 |
| CD40L ANTIBODIES AND METHODS OF TREATING CD40L RELATED DISEASES AND DISORDERS |
2016 |
- Lincecum John M.
- Jiang Bingbing
- Perrin Steven N.
- Gill Alan
- Gill Cynthia A.
- Vieira Fernando G.
|
RU2727646C2 |
| PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING AND/OR TREATING A DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF REDUCING OR LOSING ACTIVITY OF THE BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED COAGULATION FACTOR VIII |
2015 |
|
RU2721910C2 |
| COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASE CONTAINING SUBSTANCE SPECIFICALLY BINDING WITH VIMENTINE DERIVATIVE PEPTIDE |
2018 |
- Kim Yoon-Won
- Park Sungman
- Kim Min Soo
|
RU2751486C1 |
| FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE |
2019 |
- Kertis, Majkl Stiven
- Storek, Majkl
- Vajolett, Sheliya Mari
- Kalled, Syuzan L.
- Fakhnou, Kelli S.
- Khuan, Chen Zhan
- Stark, Ellen Garber
- Tejlor, Frederik Robbins
- Karavella, Dzhastin Endryu
- Kholers, Vernon Majkl
|
RU2824402C2 |
| METHOD FOR PREVENTION AND TREATMENT OF CANCER METASTASES AND BONE LOSS CAUSED BY CANCER METASTASES |
2007 |
|
RU2470665C2 |
| DOSES AND ADMINISTRATION OF ANTIBODIES AGAINST C5 FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) |
2020 |
- Pejton, Lori
- Miks, Kristian
- Pradkhan, Radzhendra
- Damokosh, Andryu
- Svenson, Yudzhin Skott
- Gao, Syan
|
RU2822664C2 |
